Herbal COVID-19 antivirals
Developing antiviral interventions from local medicinal plants and their endophytes, screening for activity against SARS-CoV-2.
The COVID-19 Drug Development and Trials Research Consortium brings six institutions together to validate and develop natural medicinal products, food supplements and technologies that strengthen Kenya's healthcare system.
Lower respiratory infections rank among the leading causes of death in Kenya, and the COVID-19 pandemic placed further strain on an already burdened healthcare system. Kenya is endowed with abundant medicinal flora used by communities for generations — but these options have rarely been validated for safety or efficacy.
Our consortium coordinates six institutions to scientifically validate and develop those natural products, integrate quality-assured traditional medicine into the national healthcare system, and build a national platform for natural product research.
From antiviral herbal formulations and immune-boosting supplements to antimicrobial sprays, functional foods and policy reform — every project feeds a single national platform.
Developing antiviral interventions from local medicinal plants and their endophytes, screening for activity against SARS-CoV-2.
Harnessing indigenous edible herbs and vegetables to produce affordable, natural immunity-boosting supplements.
Documenting remedies, establishing quality fingerprints and building a regulated evidence base for integration into care.
Formulating copper-plant extract biocides and sprays to disinfect surfaces and personal protective equipment.
Producing nutritious, easy-to-distribute Smart® food products from activated edible mushrooms for vulnerable populations.
Reviewing fragmented guidelines and building the technology that connects clinicians, healers and the public.
Coordinated by KEMRI and funded by the National Research Fund, the consortium unites five universities and a national research institute — working alongside the Herbalists Society of Kenya.






Kenyatta University hosted the consortium's first stakeholder consultative symposium with the Herbalists Society of Kenya.
Read more →
The consortium received over Ksh 50 million in seed funding from the National Research Fund for COVID-19 drug development.
Read more →
Researchers and local herbalists survey medicinal plants, vegetables and mushrooms with potential to mitigate COVID-19.
Read more →We welcome collaborators, researchers, investors and institutions working to bring safe, evidence-based natural products into mainstream healthcare.